Equine neutrophil antibody was raised in rabbits inoculated with equine neutrophils isolated to purity > 99.0%, using Percoll density-gradient sedimentation. Neutrophil antibody was detected by use of agar gel diffusion, leukoagglutination, indirect immunofluorescence, staphylococcal protein A and streptococcal protein G binding, and phagocytic inhibition techniques. Precipitin lines and leukoagglutination were seen in antiserum dilutions of 1:4 and 1:64, respectively. The specific nature of leukoagglutination was characterized by the formation of rosette-like clumps of neutrophils. Specific bright membranous fluorescence was seen in neutrophils treated with the antiserum and exposed to fluorescein-conjugated goat anti-rabbit immunoglobulin, and staphylococcal protein A and streptococcal protein G. Whereas the indirect immunofluorescence and protein G-binding tests were equally sensitive and resulted in titer of 1:256, the protein A-binding test was less sensitive and resulted in titer of only 1:32. Nonspecific binding of protein A and protein G was noticed as uniform or patchy cellular fluorescence in a small number of neutrophils. Treatment of neutrophils with antiserum up to dilution of 1:8 resulted in a significant (P < 0.05) suppression of phagocytosis of opsonized zymosan particles. Thus, protein G-binding and indirect immunofluorescence tests are highly sensitive to detect neutrophil antibody and may be used to diagnose immune-mediated neutropenias in horses and, possibly, in other animal species.

The immune status of chickens, pigs and calves depends on the content of protective factors in incubatory egg, mother colostrum and timely transfer to their posterity. At young growth in postnatal ontogenesis it is allocated three age immune deficiencies. The first is connected with untimely receipt transovarian and colostoral factors of the protection, the second is caused by an expenditure of passively transferred protective factors of protection and immaturity of own immune system. The third age immune deficiency arises at sharp transfer of young growth into new type of feeding and concerns, first of all, disorders of local protection of a digestive path. Timely application the probiotic enterobifidin, baktril-2, bifidoflorin, developed by Vitebsk State Academy of Veterinary Medicine together with Institute of microbiology of the National Academy of Sciences of Belarus, microbic polysaccharides salmopul and vistimulin, received together with Vitebsk biofactory, and also diamiksan allows to prevent development of immune deficiencies and on their background gastroenteric and respiratory diseases of young growth, to stimulate animal growth and to improve quality of meat production, decrease economic efficiency and ecological safety, considerably allows to reduce application of antimicrobic preparations (antibiotics, Sulfanilamidum, Nitrofuranums, etc.) | Иммунный статус цыплят, поросят и телят зависит от содержания защитных факторов в инкубационном яйце, молозиве матерей и своевременной передаче их потомству. У молодняка в постнатальном онтогенезе выделяется три возрастных иммунных дефицита. Первый связан с несвоевременным поступлением трансовариальных и колостральных факторов защиты, второй обусловлен расходованием пассивно перенесенных защитных факторов защиты и незрелостью собственной иммунной системы. Третий возрастной иммунный дефицит возникает при резком переводе молодняка на новый тип кормления и касается, прежде всего, нарушения местной защиты пищеварительного тракта. Своевременное применение пробиотиков энтеробифидина, бактрила-2, бифидофлорина, разработанных Витебской государственной академией ветеринарной медицины совместно с Институтом микробиологии НАН Беларуси, сальмопула и витстимулина, совместно полученных с Витебской биофабрикой микробных полисахаридов, а также диамиксана позволяет профилактировать развитие иммунных дефицитов и возникающих на их фоне желудочно-кишечных и респираторных болезней молодняка, стимулировать рост животных и улучшать качество мясной продукции, повышать экономическую эффективность и экологическую безопасность, значительно сократить применение противомикробных препаратов (антибиотиков, сульфаниламидов, нитрофуранов и др.)